EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease

Sanaz Arezoumandan iD, Katheryn A Q Cousins iD, Daniel T Ohm, MaKayla Lowe, Min Chen, James Gee, Jeffrey S Phillips iD, Corey T McMillan, Kelvin C Luk, Andres Deik, Meredith A Spindler, Thomas F Tropea und 7 weitere

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.51988 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Sanaz Arezoumandan und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Synucleinopathies, Parkinson Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, Institute on Aging, College of Medicine, University of Florida.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Alzheimer's disease neuropathologic change and alpha‐synucleinopathy commonly co‐exist and contribute to the clinical heterogeneity of dementia. Here, we examined tau epitopes marking various stages of tangle maturation to test the hypotheses that tau maturation is more strongly associated with beta‐amyloid compared to alpha‐synuclein, and within the context of mixed pathology, mature tau is linked to Alzheimer's disease clinical phenotype and negatively associated with Lewy body dementia.

Methods

We used digital histology to measure percent area‐occupied by pathology in cortical regions among individuals with pure Alzheimer's disease neuropathologic change, pure alpha‐synucleinopathy, and a co‐pathology group with both Alzheimer's and alpha‐synuclein pathologic diagnoses. Multiple tau monoclonal antibodies were used to detect early (AT8, MC1) and mature (TauC3) epitopes of tangle progression. We used linear/logistic regression to compare groups and test the association between pathologies and clinical features.

Results

There were lower levels of tau pathology ( β = 1.86–2.96, p < 0.001) across all tau antibodies in the co‐pathology group compared to the pure Alzheimer's pathology group. Among individuals with alpha‐synucleinopathy, higher alpha‐synuclein was associated with greater early tau (AT8 β = 1.37, p < 0.001; MC1 β = 1.2, p < 0.001) but not mature tau (TauC3 p = 0.18), whereas mature tau was associated with beta‐amyloid ( β = 0.21, p = 0.01). Finally, lower tau, particularly TauC3 pathology, was associated with lower frequency of both core clinical features and categorical clinical diagnosis of dementia with Lewy bodies.

Interpretation

Mature tau may be more closely related to beta‐amyloidosis than alpha‐synucleinopathy, and pathophysiological processes of tangle maturation may influence the clinical features of dementia in mixed Lewy‐Alzheimer's pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseSynucleinopathiesParkinson DiseaseHumansalpha-SynucleinLewy Bodiestau ProteinsAmyloid beta-PeptidesEpitopes

Substanzen

alpha-Synucleintau ProteinsAmyloid beta-PeptidesEpitopes

Autor:innen und Institutionen

  • Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Sanaz Arezoumandan, Katheryn A Q Cousins, Jeffrey S Phillips, Daniel Weintraub, David J Irwin

Förderung

  • NINDS NIH HHS
  • NIA NIH HHS
  • Institute on Aging, College of Medicine, University of Florida

Zitieren

APA

Arezoumandan, S., Cousins, K. A. Q., Ohm, D. T., Lowe, M., Chen, M., Gee, J., Phillips, J. S., McMillan, C. T., Luk, K. C., Deik, A., Spindler, M. A., Tropea, T. F., Weintraub, D., Wolk, D. A., Grossman, M., Lee, V., Chen-Plotkin, A. S., Lee, E. B., & Irwin, D. J. (2024). Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.51988

Vancouver

Arezoumandan S, Cousins KAQ, Ohm DT, Lowe M, Chen M, Gee J, et al. Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.51988

BibTeX
@article{Arezoumandan2024,
  author = {Arezoumandan, Sanaz and Cousins, Katheryn A Q and Ohm, Daniel T and Lowe, MaKayla and Chen, Min and Gee, James and Phillips, Jeffrey S and McMillan, Corey T and Luk, Kelvin C and Deik, Andres and Spindler, Meredith A and Tropea, Thomas F and Weintraub, Daniel and Wolk, David A and Grossman, Murray and Lee, Virginia and Chen-Plotkin, Alice S and Lee, Edward B and Irwin, David J},
  title = {Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.51988}
}
Kostenlos starten →